STAT3 and Sepsis: Given that IL-6 is an established therapeutic target (Martin et al., 2019; Kang et al., 2020) and Stat3 is an emerging target in managing sepsis (Hui et al., 2009; Hou et al., 2021; Lei et al., 2021), this is important for understanding the working mechanism of ACT001 in sepsis.